A major development emerged Wednesday in the state murder case against Luigi Mangione, as a Manhattan judge revealed that the defense plans to pursue a psychiatric argument at trial.

During a court hearing, Manhattan Supreme Court Judge Gregory Carro indicated that Mangione’s legal team intends to argue that he was experiencing an “extreme emotional disturbance” at the time of the December 2024 killing of UnitedHealthcare CEO Brian Thompson.

The defense strategy signals that Mangione’s attorneys are expected to focus not on disputing the event itself, but on his mental state during the incident as the case moves toward trial.

Psychiatric defenses can become some of the most closely watched and heavily debated elements of criminal proceedings because they shift attention toward questions surrounding intent, state of mind, and legal responsibility at the time of the alleged offense.

The announcement immediately drew attention because of the high-profile nature of the case and the public interest surrounding the killing of a major corporate executive.

Prosecutors and defense attorneys are now expected to continue preparing for what could become one of the most closely followed criminal trials in the country. As proceedings continue, the court will ultimately determine how the psychiatric defense is presented and what weight, if any, it carries during the trial.

For now, the revelation marks a significant turning point in the legal strategy surrounding the case and sets the stage for an intense courtroom battle in the months ahead. Whatever arguments are presented, the trial process will now move forward with increased focus on both the facts of the case and the legal questions surrounding mental state and accountability.